Emsita D 5mg/50mg Tablet: Managing Type 2 Diabetes

Emsita D is a combined medication that contains Dapagliflozin (5mg) and Sitagliptin (50mg). This tablet works in tandem to effectively lower blood sugar levels for adults with Type 2 diabetes.

How it Works:
* Dapagliflozin improves glucose control by acting on the kidneys to decrease glucose reabsorption, resulting in increased urinary excretion of glucose.
* Sitagliptin inhibits the enzyme dipeptidyl peptidase-4 (DPP-4), which breaks down incretin hormones that stimulate insulin release from the pancreas.

Benefits:
* Emsita D is a convenient option for managing Type 2 Diabetes, offering long-acting effectiveness in controlling blood sugar levels.

Before use:
Consult your physician before initiating or changing medication to ensure appropriate dosage and safety. This information should not be considered medical advice; always seek professional guidance for individual treatment plans.

Please note: Consult a healthcare professional for personalized advice regarding this medication.